PharVision Advisers’s StepStone Group STEP Stock Holding History

PharVision Advisers’s Portfolio STEP Stock Details STEP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,097	Closed	-$202K	–	989
2025 Q3	$202K	Buy	+3,097	New	+$189K	0.11%	512

Other funds holding STEP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PWA

Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's STEP Position: Q4 2025 in Review

PharVision Advisers sold out of StepStone Group (STEP) in Q4 2025, closing a stake of 3,097 shares — an estimated $202K sold.

PharVision Advisers first reported a position in STEP in Q3 2025 and held it in 1 quarter. The position peaked at $202K in Q3 2025. 260 funds tracked by Wall St. Rank hold STEP as of Q4 2025.

PharVision Advisers reported no remaining StepStone Group position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 3,097 StepStone Group shares in Q4 2025, an estimated $202K.
PharVision Advisers first reported a position in StepStone Group in Q3 2025 and held it in 1 quarter.
PharVision Advisers's StepStone Group position peaked at $202K in Q3 2025.
260 funds tracked by Wall St. Rank held StepStone Group as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.